Claire's makeup products contain asbestos, according to FDA test results - TODAYShow
The FDA then conducted its own independent tests and found asbestos in the three products as well as one sold by the retailer Justice that had already been recalled in 2017.The agency advised not to use Claire’s Eye Shadows, batch/lot No: 08/17; Claire’s Compact Powder, batch/lot No.: 07/15; and Claire’s Contour Palette, batch/lot No.: 04/17. The FDA noted it has not received any reports of people being sickened after using the makeup.
"If it does have asbestos particles, you can't smell them or see them, so of course you'll inhale them,'' she said."If you're inhaling asbestos long term, that can cause lung cancer, mesothelioma and other issues. If a tween or teenager uses makeup products containing asbestos from the age of 10 until 20, that would be considered long-term exposure.
When McCormack tests to see if a patient is having dermatitis or an allergic reaction to makeup, she also contacts the makeup company for the complete list of ingredients in their products. The Claire's makeup products did not list asbestos as an ingredient, so they would not have necessarily been flagged by a doctor.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Lire la suite »
Reynolds tobacco debuts e-cigarette commercial, tightens online vape sales to combat teen useReynolds is also tightening online sales as the FDA weighs e-cigarette regulations.
Lire la suite »
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Lire la suite »
FDA puts 15 national retailers on notice for allegedly selling tobacco products to minorsThe Food and Drug Administration called out 15 retailers on Monday for allegedly selling tobacco products to minors.
Lire la suite »
FDA Commissioner Scott Gottlieb is resigning
Lire la suite »
Biotech shares continue to fall on FDA uncertaintyThe biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week's surprise announcement from FDA chief Scott Gottlieb that he will be stepping down next month.
Lire la suite »
Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Lire la suite »
FDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Lire la suite »
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.
Lire la suite »